Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Plaque-type Psoriasis”

65 trials

Showing 20 of 65 results

Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Not applicableStudy completedNCT00098189
What this trial is testing

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Novartis
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT03553823
What this trial is testing

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT03724292
What this trial is testing

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Who this might be right for
Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate 40
Testing effectiveness (Phase 2)Study completedNCT02173301
What this trial is testing

Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 200
Not applicableUnknownNCT01339741
What this trial is testing

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

Who this might be right for
Psoriasis VulgarisVitamin D Deficiency
Chulalongkorn University 30
Large-scale testing (Phase 3)Study completedNCT01815424
What this trial is testing

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 266
Testing effectiveness (Phase 2)Study completedNCT00770965
What this trial is testing

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 80
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Large-scale testing (Phase 3)Study completedNCT01544595
What this trial is testing

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 1,147
Testing effectiveness (Phase 2)Study completedNCT03384745
What this trial is testing

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Bond Avillion 2 Development LP 313
Testing effectiveness (Phase 2)Ended earlyNCT00427609
What this trial is testing

Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications

Who this might be right for
Psoriasis
University of Tennessee 5
Testing effectiveness (Phase 2)Study completedNCT00805480
What this trial is testing

Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 130
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT01828086
What this trial is testing

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 95
Large-scale testing (Phase 3)Study completedNCT01640951
What this trial is testing

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-Type Psoriasis
Novartis Pharmaceuticals 675
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation